Table 1.

CGD patient characteristics and IFN-γ dosea

Patient no.Age (yr)/genderbCGD typecDose of IFN-γ (μg/m2)
16/FAutosomal, not defined100
27/MX910 50
317/MX910 100
49/MX910 50
517/MX910 50
616/FA670 50
733/MA470 100
822/MA470 50
  • a No patient had an oxidative capacity.

  • b F, female; M, male.

  • c The numbers 91, 47, and 67 indicate the defective phox proteins. X, X-linked inheritance; A, autosomal recessive; superscript zero, undetectable protein on immunoblot.